Investor Relations

Integrum är listat på Nasdaq First North Stockholm

Handelsplats: Nasdaq First North Stockholm
Handlas i: SEK
Kortnamn aktie : INTEG B
ISIN: SE0009807266
LEI-kod : 549300L5CG5PX4514U49

Integrum has since the start in 1990 been helping individuals with amputations towards an improved quality of life. A thorough experience in osseointegration has generated a system for bone-anchored prostheses – a beneficial alternative to the traditionally used socket prosthesis. Integrum is world leading in this area, with patients from all parts of the world treated in 14 clinical centers. Performing continuous research and development, Integrum aims at providing safe medical devices, supporting a more active life-style and improving quality of life. In order to meet individual needs, custom-made solutions are developed in close collaboration with scientists and clinicians. The OPRA Implant System has been used in over 500 surgeries since the start in 1990.

Vision

Our vision is to continuously lead the improvement of medical devices using evidence based development.

Mission

Our mission is to provide safe medical devices that will improve quality of life for individuals with amputations.